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authors admit, data gathered in normal, anesthetized patients can, in
no way, be extrapolated to patients who are the usual recipients of
implanted defibrillators .
We believe that there is a powerful lesson to be learned from this
study . The value of clinical investigation, even in a subject area as
critical as treatment of sudden death, must be carefully weighed
against potential hazards . The responsibility for making this key
benefit/risk assessment is squarely the investigator(s) who conceive
and carry out the project . II cannot be made by an ethical review
panel because members of such a committee frequently lack the
scientific expertise to make difficult value judgments . Neither can
investigators depend on patient consent, which in these complicated
studies is seldom fully informed.
We sincerely respect the expertise of our distinguished col-
leagues and are therefore reluctant to criticize their work . However,
we feel that airing of these complex issues should help to focus
investigative work in this very important problem area, hopefully
avoiding a headlong plunge into technocracy without careful con-
sideration of the patient-subject .
PETER R. KOWEY, MD, FACC
TED D . FRIEHLING . MD. FACC
ROGER A. MARINCHAK, MD, FACC
Division of Cardiology
The Medical College ott Pennsylvania
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Reply
We
hope
that the following clarifications will alleviate the concerns
of Kowey and colleagues .
The placing of the word "volunteers" in parentheses would
suggest that Kowey et al . feel that tae informed consent was not
provided
. A detailed written consent form was explicitly discussed
with each patient, and generally their relatives, by one of the
principal investigators (generally G.J .K .) . The investigators were
satisfied beyond doubt that the volunteer nature of the study and its
implications were understood by each patient . We did not consider
patients under the age of 19 for this protocol, nor did we consider
patients who were felt to be emotionally or intellectually incapable
of providing informed consent
. Patients undergoing electrical sur-
gery for cardiac arhythmias generally have had considerable diffi-
culty with arrhythmias and have often required multiple cardiover-
sions during the course of their therapy . These patients generally
understand the implications of tachycardia and cardioversion and
have a high degree of empathy for similar patients and a greater
motivation for advances in the field . For this reason, the acceptance
rate for this and other similar protocols in our patients is approxi-
mately 75% . The mechanics of the procedure in the operating room
surrounding the protocol were made very clear to each patient and
the request for participation in the protocol was always low key and
never involved coercion.
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Kowey et al . former state that "four titanium mesh plaque
electrodes were sutured to the epicardium ." Patients undergoing
electrosurgery generally have two or more plaque electrodes sewn
on the epicardium with fine sutures for the purposes of electrogram
recording and programmed stimulation . In our experience with
>4W patients undergoing electrosurgery, all done by G .M. Guirau-
don, we have never encountered a difficulty with these and consider
their application on the epicardium to be trivial . The placing of the
plaque electrodes for the protocol was identical to the procedure
used for our diagnostic plaques and we have never had the remotest
indication of a problem with these techniques. Kowey et al. under-
line that defibrillation was attempted in the warm beating beam after
a "minimum" of 10 s after induction of ventricular fibrillation . The
great majority of investigators in this field use at least 10 s after
induction of ventricular fibrillation to ensure that the arrhythmia is
not wit-terminating and it is difficult to see why this is a concern .
The technique of defibrillation threshold testing requires that the
voltage be increased until conversion occur . Kowey et al. states that
the "total" duration of arrest for each patient was 59 ± 23 s .
However, this is a "total" arrest time encompassing two or three
episodes. In fact, the mean duration of ventricular fibrillation for
each individual episode was on the order of 25 s . We recorded the
electroencephalogram in a systematic way in approximately 30
patients during these procedures (Dr. 1 . Markin, Department of
Anacslhcsia, unpa tlished observations) and noted no
electroence-
phalogram
changes during this time course . There is absolutely no
indication that such brief periods of ventricular fibrillation in a
normal heart have any adverse effect . Indeed, the general period of
hypoperfusion occurring during mapping of rapid tachycardias (op-
timally done on the rarmothermic heart in the absence of bypass) is
approximately 30 to 45 s before terminating the tachycardia for a
"rest" for our routine procedures. Ventricular fibrillation occurs
frequently in the course of mapping of taohyeardias in electroturg-
ery and these are not considered to have an adverse effect on
outcome.
We are pleased that Kowey et al . believe that the study has some
merit . However, we canna agree that young patients with a normal
heart were exposed to "substantial risk of cardiac arrest" and we
emphasize that individual ventricular fibrillation episodes were
generally terminated within 30 s . We do not agree that this sequence
was "frequently repeated
." Most patients had two episodes of
ventricular fibrillation and a few patients had a third episode when
conversion in one of them occurred immediately after the first test
shock, which by definition was 10 s after induction
. We cannot agree
that the leads sutured to the epicardium and removed pose a risk
because diagnostic plaque electrodes routinely placed on the epicar-
dium are done in identical fashion . Kowey
et al
. comment that we
did not discuss complications. No adverse effects were listed
because there were none, and all patients in this series had an
unremarkable postoperative course with discharge from hospital on
the 6th to the 8th postoperative day. Patients routinely are in an
intensive cam unit for 24 h with continuous electrocardiographic
monitoring for 48 h
. All patients have electrophysiologic testing
before discharge. Measurements of cardiac enzymes postopera-
tively in selected patients performed for other purposes (G .M
.
Guiraudon, unpublished observations) have
shown no significant
enzyme increases with a closed heart epicardial approach, whether
or not the patients have had defibrillation .
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Kowey et al. further question the relevance of defibrillation data
in normal anesthetized patients, and we agree that such data are not
optimal . However, similar studies in unanesthetized patients are
clearly impossible
. In addition, the performance of research proto-
cols in patients with severe left ventricular dysfunction undergoing
concomitant surgery and implantation of defibrillaors is severely
limited to the bare essentials required for their care. Consequently .
we believe that studies in normal anesthetized patients still provide
a valuable model and data that cannot otherwise be obtained .
We agree entirely with the generic comments on the importance
of critically assessing the potential information from any research
protocol and weighing it against the risk to the patient subject . Such
research must always be carried out with the highest degree of
expertise and utmost consideration for the safety of the patient
subject, who should fully understand the consequences of the
protocol. Every clinical investigator is constantly walking the tight-
rope between the accumulation of data of potential benefit to future
patients and the risk and inconvenience to the patient subject . The
clinical research must be carried out in the background of a high
standard of expertise and assurance that no harm is being done. We
believe that our experience with >300 operations for supravemri-
cular tachycardia (without mortality) qualify us to be cognizant of
the risks to the patient resulting from our procedures. In the final
analysis, each investigator must answer to his or her own con-
science and we have done this .
GEORGE J. KLEIN . MD. FACC
DOUGLAS L . JONES
Cardiac Investigation Unit
University Hospital
P.O
. Bas,
5339,
Postal Station A
London, Ontario, Canada NSA 5A5
The Rhythm Library and
Defibrillator Performance
Cummins et al . (I) addressed the important issue of evaluating
automatic defibrillator algorithms for detecting ventricular fibrilla-
lion
. They suggest that testing a device with a library of recorded
electrocardiographic rhythms could
assist
in device evaluations.
They also conclude that clinical field trials are necessary to evaluate
overall device performance
. What they fail to point out is that
testing devices against such a data base can substantially overesti-
mate or underestimate device performance (2). It would, therefore,
seem prudent for the authors to compare their estimates of rhythm
recognition performance (and overall system performance) for the
taped library with actual rhythm recognition performance in the
clinical studies of the three commercially available devices . In this
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way, they could substantiate the value of the analysis they de-
scribed. Without such a comparison one can only speculate on the
validity or such a test.
CLIF ALFERNESS
Director, Research
Physio Control
11811 Willows Road Northeast
P.O. Box 97006
Redmond, Washington 98073-9706
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Tnese comments raise interesting questions about product develop-
ment. Fine tuning automatic external defibrillators by clinical trials
should be avoided . Our rhythm library is an effort to provide as
much information as possible about the performance of automatic
external defibrillators before clinical use
. There is not a need for a
comparison of the bench versus the field-rather, one follows the
other . Rhythm libraries are an appropriate first step in the sequence
of development.
Th: cited study of Weaver et al. makes clear that the perfor-
c of an automatic external defibrillator will diminish when it
moves from in vitro testing to clinical use. This is because, itde-
perLent of algorithm performance, there are operator and machine
errors that can prevent successful defibNlation of patients in ven-
tricular fibrillation . We stated our agreement with this observation
several times in our report
. Clinical tests in patients evaluate the
total system of an automatic external defibillator (electrodes, oper-
ator performance. device controls and algorithms for static and
dynamic impedance levels) . The article by Weaver et al ., however,
provided no information on how often these other dimensions of
perfnrmance caused failure to shock. In addition, the data reported
by Weaver et al . may be interpreted not as demonstrating a need for
more extensive clinical tests, but as demonstrating the need for
bract rhythm libraries . The magnitude of the discrepancy between
laboratory and clinical performance can, we think, be minimized by
a widely available, high quality, nonproprielary rhythm library. We
tested three automatic external defibrillators against our rhythm
library. Their performance levels (all of which were acceptable)
should stand as an in vitro standard for other products to meet . If
future devices perform as well against our rhythm library as the
currently available devices did, then they can move from the bench
to the field .
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